$163.20
-0.49-0.3%
Last update: Nov 10, 1:45 PM
Novartis AG (NVS) Stock Price, Quote, News & History
NVSNYSE
Novartis beat Q3 adjusted earnings estimates despite a $1.9 billion Avidity impairment charge, lifted by strong sales of Kisqali, Kesimpta, and revised...
You can purchase shares of Novartis (NYSE:NVS) through any online brokerage.
Other companies in Novartis’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), AstraZeneca PLC (NYSE:AZN) and Novo Nordisk AS (NYSE:NVO).
Novartis has a consensus price target of $134.80.
The stock price for Novartis (NYSE: NVS) is $163.2 last updated November 10, 2026 at 1:45 PM EST.
There are no upcoming dividends for Novartis.
Novartis does not have any upcoming earnings scheduled.
There is no upcoming split for Novartis.
Novartis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises....
